1. Epidimology of colorectal cancer
2. Colorectal cancer: A model for the study of cancer immunology3.
Impact of Covid-19 Pandemic on Gastro Intestinal Cancer Patients:
An Emphasis on Colorectal Cancer
4. Potential role of NMR and MRI in colon cancer
5. Role of micro-RNA in-situ hybridization in colon cancer
diagnosis
6. Role of epigenetics in colorectal cancer
7. Exosomal biomarkers in colorectal cancer
8. Biomarkers as putative therapeutic targets in colorectal
cancer
9. Proteins involved in colorectal cancer:
Identification strategies and possible roles
10. Short-chain fatty acids as therapeutic agents in
colon malignancies
11. Targeting of angiogenesis for colorectal cancer
therapy
12. Anti‐inflammatory molecular mechanism and
contribution of drug transport molecules in colorectal cancer
cells
13. Emerging role of circulating tumour DNA in
treatment response prognosis in colon cancer
14. Immuno-modulating mediators of colon cancer as
immunotherapeutic: mechanism and potential15. Immune
checkpoint inhibitors as armor for targeted immunotherapy of
colorectal cancer16. Examining the role of the MACC1
gene in colorectal cancer metastasisIndex
Dr. Nagaraju GP is a faculty member in the Department of
Hematology and Medical Oncology at Emory University School of
Medicine. Dr. Nagaraju obtained his MSc and PhD, both in
Biotechnology from Sri Venkateswara University in Tirupati, Andhra
Pradesh, India. Dr. Nagaraju received his D.Sc. from Berhampur
University in Berhampur, Odisha, India. Nagaraju's research focuses
on translational research in gastrointestinal malignancies. He has
published over 100 research papers in highly respected
international journals and has presented more than 50 abstracts at
various national and international conferences. He is the author
and editor of several books. Dr. Nagaraju is an editorial board
member of several internationally recognized academic journals, and
is an associate member of the Discovery and Developmental
Therapeutics research program at Winship Cancer Institute. He is a
member of the Association of Scientists of Indian Origin in America
(ASIOA), the Society for Integrative and Comparative Biology
(SICB), the Science Advisory Board, The RNA Society and the
American Association of Cancer Research (AACR).
Dr. Dhananjay Shukla is an Assistant Professor in the
Department of Biotechnology at Guru Ghasidas Vishwavidyalaya (A
Central University) in India. Dr. Shukla received his PhD in
Biotechnology from Defense Institute of Physiology and Allied
Science, New Delhi, India. Dr. Shukla has expertise in cancer
physiology and has published more than 25 research papers in
various highly reputed international journal. He has presented and
been invited to lecture at a number national and international
conferences.
Dr. Naveen Kumar Vishvakarma is an Assistant Professor in
the Department of Biotechnology at Guru Ghasidas Vishwavidyalaya (A
Central University) in India. Dr. Vishvakarma received his PhD in
Biotechnology from Banaras Hindu University, Varanasi, India. He
has published more than 20 research papers in highly reputed
journals on various aspects of cancer biology. He has written a
number of book chapters for international publishers and presented
abstract at national and international conferences.
Ask a Question About this Product More... |